Atea Pharmaceuticals Inc (AVIR): Next-Year EPS Estimate 28.05%
As of 2026-06-04, Atea Pharmaceuticals Inc (AVIR) has a next-year EPS growth estimate of 28.05%.
On 2026-05-17, analyst consensus for AVIR's next-year EPS growth shifted from 28.31% to 28.05% — a negative change of 0.26 percentage points. The revised estimate has been sustained across 15 subsequent trading sessions. Current-year growth is projected at 0.77%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 28.05%
- EPS growth this year
- 0.77%
- EPS next quarter (est)
- -$0.56
- Last price
- $4.42
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 28.05% | 0.77% | -$0.56 | $4.42 |
| 2026-06-03 | 28.05% | 0.77% | -$0.56 | $4.21 |
| 2026-06-02 | 28.05% | 0.77% | -$0.56 | $4.27 |
| 2026-06-01 | 28.05% | 0.77% | -$0.56 | $4.38 |
| 2026-05-31 | 28.05% | 0.77% | -$0.56 | $4.67 |
| 2026-05-28 | 28.05% | 0.77% | -$0.56 | $4.73 |
| 2026-05-27 | 28.05% | 0.77% | -$0.56 | $4.55 |
| 2026-05-26 | 28.05% | 0.77% | -$0.56 | $4.53 |
| 2026-05-25 | 28.05% | 0.77% | -$0.56 | $4.42 |
| 2026-05-24 | 28.05% | 0.77% | -$0.56 | $4.42 |
| 2026-05-21 | 28.05% | 0.77% | -$0.56 | $4.24 |
| 2026-05-20 | 28.05% | 0.77% | -$0.56 | $4.19 |
| 2026-05-19 | 28.05% | 0.77% | -$0.56 | $4.15 |
| 2026-05-18 | 28.05% | 0.77% | -$0.56 | $4.14 |
| 2026-05-17 | 28.05% | 0.77% | -$0.56 | $4.10 |
| 2026-05-14 | 28.31% | 0.77% | -$0.56 | $4.27 |
| 2026-05-13 | 28.31% | 0.77% | -$0.56 | $4.67 |
| 2026-05-12 | 28.24% | 0.52% | -$0.56 | $5.50 |
| 2026-05-11 | 28.24% | 0.52% | -$0.56 | $5.41 |
| 2026-05-10 | 28.24% | 0.52% | -$0.56 | $5.43 |
| 2026-05-07 | 28.24% | 0.52% | -$0.56 | $5.54 |
| 2026-05-06 | 28.24% | 0.52% | -$0.56 | $5.65 |
| 2026-05-05 | 28.24% | 0.52% | -$0.56 | $5.60 |
| 2026-05-04 | 28.24% | 0.52% | -$0.56 | $5.70 |
| 2026-05-03 | 28.24% | 0.52% | -$0.56 | $5.58 |
| 2026-04-30 | 28.24% | 0.52% | -$0.56 | $5.51 |
| 2026-04-29 | 28.23% | 0.48% | -$0.56 | $5.43 |
| 2026-04-28 | 28.23% | 0.48% | -$0.56 | $5.58 |
| 2026-04-27 | 28.23% | 0.48% | -$0.56 | $5.36 |
| 2026-04-26 | 28.23% | 0.48% | -$0.56 | $5.47 |
Recent News
- Atea Pharmaceuticals, Inc. Q1 2026 Earnings Call SummaryMoby
- Atea Pharmaceuticals to Present Three Abstracts at EASL 2026 Congress Highlighting Progress Across Viral Hepatitis PipelineGlobeNewswire
- Atea Pharmaceuticals Inc (AVIR) Q1 2026 Earnings Call Highlights: Strategic Advancements and ...GuruFocus.com
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Atea Pharmaceuticals Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Atea Pharmaceuticals Inc (AVIR) has a next-year EPS growth estimate of 28.05%, based on analyst consensus.
When was the latest EPS estimate revision for AVIR?▾
The most recent revision occurred on 2026-05-17, when analysts adjusted the next-year EPS growth estimate from 28.31% to 28.05%.
What sector and industry does Atea Pharmaceuticals Inc belong to?▾
Atea Pharmaceuticals Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. AVIR appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Atea Pharmaceuticals Inc (AVIR) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports